The low molecular weight GTP-binding proteins RhoA, RhoB, and RhoC are characterized as specific substrates for the ADP-ribosyltransferase C3 from Clostridium botulinum and are supposed to be involved in the organization of the microfilamental network and transformation. rhoB is known to be immediate-early inducible by growth factors and protein-tyrosine kinases. Since increasing evidence indicates overlapping of growth factor- and UV-induced signal pathways, we studied the effect of UV light and other genotoxic agents on early rhoB transcription. Within 30 min after UV irradiation of NIH3T3 cells, the amount of rhoB mRNA increased 3-4-fold. Elevated rhoB mRNA was accompanied by an increase in RhoB protein, as detected by C3-mediated [P]ADP-ribosylation. The transcription inhibitor actinomycin D prevented the UV-induced increase in rhoB mRNA and proved rhoB mRNA to be unstable with a half-life of 20 min. Transcriptional activation of rhoB by UV light was confirmed by run-on analysis. The increase in rhoB mRNA after UV irradiation was prevented by inhibitors of protein kinase A (H9) and C (H7, Gö18). The tyrosine kinase inhibitor genistein did not affect UV induction of rhoB. In addition to UV, N-methyl-N-nitrosourea and the cytostatic drug cisplatin evoked rhoB response. Cycloheximide was likewise effective in increasing the amount of rhoB mRNA, whereas BtcAMP, 12-O-tetradecanoylphorbol-13-acetate, and retinoic acid were without effect. Prior down-regulation of signaling by 12-O-tetradecanoylphorbol-13-acetate and serum pretreatment reduced UV-stimulated rhoB expression. The data indicate that rhoB represents a novel DNA damage-inducible function involved in early steps of signal transduction upon genotoxic stress.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				I. Lajoie-Mazenc, D. Tovar, M. Penary, B. Lortal, S. Allart, C. Favard, M. Brihoum, A. Pradines, and G. Favre MAP1A Light Chain-2 Interacts with GTP-RhoB to Control Epidermal Growth Factor (EGF)-dependent EGF Receptor Signaling J. Biol. Chem., February 15, 2008; 283(7): 4155 - 4164. [Abstract] [Full Text] [PDF]

				C.-C. Wang, Y.-P. Liao, P. S. Mischel, K. S. Iwamoto, N. A. Cacalano, and W. H. McBride HDJ-2 as a Target for Radiosensitization of Glioblastoma Multiforme Cells by the Farnesyltransferase Inhibitor R115777 and the Role of the p53/p21 Pathway. Cancer Res., July 1, 2006; 66(13): 6756 - 6762. [Abstract] [Full Text] [PDF]

				N. Skuli, S. Monferran, C. Delmas, I. Lajoie-Mazenc, G. Favre, C. Toulas, and E. Cohen-Jonathan-Moyal Activation of RhoB by Hypoxia Controls Hypoxia-Inducible Factor-1{alpha} Stabilization through Glycogen Synthase Kinase-3 in U87 Glioblastoma Cells Cancer Res., January 1, 2006; 66(1): 482 - 489. [Abstract] [Full Text] [PDF]

				B. Canguilhem, A. Pradines, C. Baudouin, C. Boby, I. Lajoie-Mazenc, M. Charveron, and G. Favre RhoB Protects Human Keratinocytes from UVB-induced Apoptosis through Epidermal Growth Factor Receptor Signaling J. Biol. Chem., December 30, 2005; 280(52): 43257 - 43263. [Abstract] [Full Text] [PDF]

				N. M.G.M. Appels, J. H. Beijnen, and J. H.M. Schellens Development of Farnesyl Transferase Inhibitors: A Review Oncologist, September 1, 2005; 10(8): 565 - 578. [Abstract] [Full Text] [PDF]

				J. Pan, M. She, Z.-X. Xu, L. Sun, and S.-C. J. Yeung Farnesyltransferase Inhibitors Induce DNA Damage via Reactive Oxygen Species in Human Cancer Cells Cancer Res., May 1, 2005; 65(9): 3671 - 3681. [Abstract] [Full Text] [PDF]

				R. Gerhard, H. Tatge, H. Genth, T. Thum, J. Borlak, G. Fritz, and I. Just Clostridium difficile Toxin A Induces Expression of the Stress-induced Early Gene Product RhoB J. Biol. Chem., January 14, 2005; 280(2): 1499 - 1505. [Abstract] [Full Text] [PDF]

				M. Wherlock, A. Gampel, C. Futter, and H. Mellor Farnesyltransferase inhibitors disrupt EGF receptor traffic through modulation of the RhoB GTPase J. Cell Sci., July 1, 2004; 117(15): 3221 - 3231. [Abstract] [Full Text] [PDF]

				K. Jiang, J. Sun, J. Cheng, J. Y. Djeu, S. Wei, and S. Sebti Akt Mediates Ras Downregulation of RhoB, a Suppressor of Transformation, Invasion, and Metastasis Mol. Cell. Biol., June 15, 2004; 24(12): 5565 - 5576. [Abstract] [Full Text] [PDF]

				J. Mazieres, T. Antonia, G. Daste, C. Muro-Cacho, D. Berchery, V. Tillement, A. Pradines, S. Sebti, and G. Favre Loss of RhoB Expression in Human Lung Cancer Progression Clin. Cancer Res., April 15, 2004; 10(8): 2742 - 2750. [Abstract] [Full Text] [PDF]

				S. Chauhan, S. Kunz, K. Davis, J. Roberts, G. Martin, M. C. Demetriou, T. C. Sroka, A. E. Cress, and R. L. Miesfeld Androgen Control of Cell Proliferation and Cytoskeletal Reorganization in Human Fibrosarcoma Cells: ROLE OF RhoB SIGNALING J. Biol. Chem., January 9, 2004; 279(2): 937 - 944. [Abstract] [Full Text] [PDF]

				T. B. Brunner, S. M. Hahn, A. K. Gupta, R. J. Muschel, W. G. McKenna, and E. J. Bernhard Farnesyltransferase Inhibitors: An Overview of the Results of Preclinical and Clinical Investigations Cancer Res., September 15, 2003; 63(18): 5656 - 5668. [Abstract] [Full Text] [PDF]

				T. Kamai, T. Tsujii, K. Arai, K. Takagi, H. Asami, Y. Ito, and H. Oshima Significant Association of Rho/ROCK Pathway with Invasion and Metastasis of Bladder Cancer Clin. Cancer Res., July 1, 2003; 9(7): 2632 - 2641. [Abstract] [Full Text] [PDF]

				J. C. Chen, S. Zhuang, T. H. Nguyen, G. R. Boss, and R. B. Pilz Oncogenic Ras Leads to Rho Activation by Activating the Mitogen-activated Protein Kinase Pathway and Decreasing Rho-GTPase-activating Protein Activity J. Biol. Chem., January 24, 2003; 278(5): 2807 - 2818. [Abstract] [Full Text] [PDF]

				R. R. Mattingly, R. A. Gibbs, R. E. Menard, and J. J. Reiners Jr. Potent Suppression of Proliferation of A10 Vascular Smooth Muscle Cells by Combined Treatment with Lovastatin and 3-Allylfarnesol, an Inhibitor of Protein Farnesyltransferase J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 74 - 81. [Abstract] [Full Text] [PDF]

				J. Adnane, C. Muro-Cacho, L. Mathews, S. M. Sebti, and T. Munoz-Antonia Suppression of Rho B Expression in Invasive Carcinoma from Head and Neck Cancer Patients Clin. Cancer Res., July 1, 2002; 8(7): 2225 - 2232. [Abstract] [Full Text] [PDF]

				J. Adnane, E. Seijo, Z. Chen, F. Bizouarn, M. Leal, S. M. Sebti, and T. Munoz-Antonia RhoB, Not RhoA, Represses the Transcription of the Transforming Growth Factor beta Type II Receptor by a Mechanism Involving Activator Protein 1 J. Biol. Chem., March 1, 2002; 277(10): 8500 - 8507. [Abstract] [Full Text] [PDF]

				A.-X. Liu, N. Rane, J.-P. Liu, and G. C. Prendergast RhoB Is Dispensable for Mouse Development, but It Modifies Susceptibility to Tumor Formation as Well as Cell Adhesion and Growth Factor Signaling in Transformed Cells Mol. Cell. Biol., October 15, 2001; 21(20): 6906 - 6912. [Abstract] [Full Text] [PDF]

				G. Fritz and B. Kaina Transcriptional activation of the small GTPase gene rhoB by genotoxic stress is regulated via a CCAAT element Nucleic Acids Res., February 1, 2001; 29(3): 792 - 798. [Abstract] [Full Text] [PDF]

				A.-x. Liu, W. Du, J.-P. Liu, T. M. Jessell, and G. C. Prendergast RhoB Alteration Is Necessary for Apoptotic and Antineoplastic Responses to Farnesyltransferase Inhibitors Mol. Cell. Biol., August 15, 2000; 20(16): 6105 - 6113. [Abstract] [Full Text]

				R. E. Favoni and A. De Cupis The Role of Polypeptide Growth Factors in Human Carcinomas: New Targets for a Novel Pharmacological Approach Pharmacol. Rev., June 1, 2000; 52(2): 179 - 206. [Abstract] [Full Text] [PDF]

				S. Montaner, R. Perona, L. Saniger, and J. C. Lacal Activation of Serum Response Factor by RhoA Is Mediated by the Nuclear Factor-kappa B and C/EBP Transcription Factors J. Biol. Chem., March 26, 1999; 274(13): 8506 - 8515. [Abstract] [Full Text] [PDF]

				G. Fritz and B. Kaina Activation of c-Jun N-Terminal Kinase 1 by UV Irradiation Is Inhibited by Wortmannin without Affecting c-jun Expression Mol. Cell. Biol., March 1, 1999; 19(3): 1768 - 1774. [Abstract] [Full Text] [PDF]

				W. Du, P. F. Lebowitz, and G. C. Prendergast Cell Growth Inhibition by Farnesyltransferase Inhibitors Is Mediated by Gain of Geranylgeranylated RhoB Mol. Cell. Biol., March 1, 1999; 19(3): 1831 - 1840. [Abstract] [Full Text] [PDF]

				M. E. Engel, P. K. Datta, and H. L. Moses RhoB Is Stabilized by Transforming Growth Factor beta  and Antagonizes Transcriptional Activation J. Biol. Chem., April 17, 1998; 273(16): 9921 - 9926. [Abstract] [Full Text] [PDF]

				G. Fritz and B. Kaina rhoB Encoding a UV-inducible Ras-related Small GTP-binding Protein Is Regulated by GTPases of the Rho Family and Independent of JNK, ERK, and p38 MAP Kinase J. Biol. Chem., December 5, 1997; 272(49): 30637 - 30644. [Abstract] [Full Text] [PDF]

				M. Aepfelbacher, M. Essler, E. Huber, M. Sugai, and P. C. Weber Bacterial Toxins Block Endothelial Wound Repair : Evidence That Rho GTPases Control Cytoskeletal Rearrangements in Migrating Endothelial Cells Arterioscler. Thromb. Vasc. Biol., September 1, 1997; 17(9): 1623 - 1629. [Abstract] [Full Text]

				R Perona, S Montaner, L Saniger, I Sanchez-Perez, R Bravo, and J C Lacal Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins. Genes & Dev., February 15, 1997; 11(4): 463 - 475. [Abstract] [PDF]

				T. Reid, T. Furuyashiki, T. Ishizaki, G. Watanabe, N. Watanabe, K. Fujisawa, N. Morii, P. Madaule, and S. Narumiya Rhotekin, a New Putative Target for Rho Bearing Homology to a Serine/Threonine Kinase, PKN, and Rhophilin in the Rho-binding Domain J. Biol. Chem., June 7, 1996; 271(23): 13556 - 13560. [Abstract] [Full Text] [PDF]

				Z. Chen, J. Sun, A. Pradines, G. Favre, J. Adnane, and S. M. Sebti Both Farnesylated and Geranylgeranylated RhoB Inhibit Malignant Transformation and Suppress Human Tumor Growth in Nude Mice J. Biol. Chem., June 9, 2000; 275(24): 17974 - 17978. [Abstract] [Full Text] [PDF]

				G. Fritz and B. Kaina Ras-related GTPase RhoB Represses NF-kappa B Signaling J. Biol. Chem., January 26, 2001; 276(5): 3115 - 3122. [Abstract] [Full Text] [PDF]

				A.-x. Liu, G. J. Cerniglia, E. J. Bernhard, and G. C. Prendergast RhoB is required to mediate apoptosis in neoplastically transformed cells after DNA damage PNAS, May 22, 2001; 98(11): 6192 - 6197. [Abstract] [Full Text] [PDF]